ArticleFrontiers in immunology2022

Corrigendum: ACTIVATE-2: A double-blind randomized trial of BCG vaccination against COVID-19 in individuals at risk.

Maria Tsilika et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.